Rentokil Initial (RTO) Trading Update summary

Financial performance and outlook

• Full-year adjusted PBTA is forecast at about £700 million, with a group adjusted operating margin of 15.5%.

• North America organic revenue growth for H2 2024 is expected to be around 1%, below previous expectations.

• North America adjusted operating profit margin for FY24 is anticipated at approximately 17.2%.

• Strengthening of sterling against the dollar is expected to create a £10 million headwind for the year.

• Leverage is expected to remain flat at around 2.8x, with no significant issues anticipated regarding debt or credit rating.

Operational challenges and actions

• Over-resourcing, higher overtime, and material costs in North America are expected to reduce group adjusted operating profit by about £50 million.

• Lower than expected sales momentum in July and August led to a downward revision of growth expectations.

• Execution issues, not market weakness, are cited as the main reason for underperformance.

• Decisive actions are being taken to manage costs, rightsize sales resources, and improve inventory and technician workload.

• The Right Way 2 plan is being implemented to boost revenue growth, improve lead flow, sales conversion, and customer retention.

Lead generation and sales productivity

• Over-reliance on paid search has increased lead costs; efforts are underway to boost organic lead flow via website improvements.

• Sales force productivity and lead conversion are key areas for improvement; right-sizing is being implemented to match resources to demand.

• Investments in marketing and sales are ongoing, but their effectiveness will take time to materialize.

• Quality and conversion of leads, not just volume, are critical to future growth.